In this study, we found that TREM2 was a regulator in accelerating the radioresistance and immune escape of GBM through participating in DNA damage repair and forming a positive feedback loop with HMGB1 to cascade the activation of TLR4/Akt signaling. The gene discussed is TREM2; the disease is glioblastoma.